Medications

Clinical trial suggests Parkinson's drug is safe in humans

A large team of researchers from Denali Therapeutics, working with colleagues from multiple entities in the U.S. and one in Canada, has found that a LRRK2 inhibitor called DNL201 showed no ill effects to volunteers in a clinical ...

Diseases, Conditions, Syndromes

Coronary heart disease risk higher with COPD

Patients with chronic obstructive pulmonary disease (COPD) are more likely to have coronary heart disease (CHD), but no specific phenotypes have a higher risk, according to a study published online April 27 in PLOS ONE.

Overweight & Obesity

Scientists study links between obesity, age and body chemistry

A team of Clemson University scientists is making inroads in understanding the relationship between certain enzymes that are normally produced in the body and their role in regulating obesity and controlling liver diseases.

page 11 from 40